Related Reports
Related Tariffs and Trade Reports
• 6APA Non sterile. HS: 2941.10.100
• Ampicillin. HS: 2941.10.200
• Amoxycillin, non sterile. HS: 2941.10.300
•Medicaments (excluding goods of heading No. 30.02, heading No. 30.05 or heading No. 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packing retail sale. HS: 30.03
•Medicaments (excluding goods of heading No. 30.02, heading No. 30.05 or heading No. 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packing for retail sale. HS: 30.04

Company News
Pyridam’s Sales Increase
Bisnis Indonesia, page B2 (3-February-2006)
Although PT Pyridam Farma Tbk’s sales all throughout last year was predicted to rise to around Rp.39 billion from Rp.33.97 billion in 2004, its net profit dropped from Rp.1.3 billion to Rp.1.43 billion. This is because the company did not increase the price of its products at all last year. Therefore, Pyridam will increase the selling price of its products by around 8 percent to 10 percent in the beginning of this year in order to adapt to increasing production costs. The minimum sector wage has also been increased as much as 23 percent this year, giving a 4 percent effect to the company’s total expenses.
Pyridam Farma Will Not Share Dividend This Year
www.tempointeraktif.com (26-May-2003)
Due to the fact that its profit dropped by 91 percent from Rp.437 million in 2003, PT Pyridam Farma did share its dividend for that year. The profit was instead used to develop the business by preparing 10 new products and also establish partnerships with Heksa Parm and Kalbe Group to manufacture pharmaceutical drugs, and with Mezza to manufacture traditional medications.

Copyright & Disclaimer
PT. Dataindo Inti Swakarsa makes no representation to any other person with regard to the completeness or accuracy of the data or information contained herein, and it accepts no responsibility and disclaims all liability (save for liability which cannot be lawfully disclaimed) for loss or damage whatsoever suffered or incurred by any other person resulting from the use of, or reliance upon, the features, functions, tools, data or information contained herein.Information provided is not financial product advice. This report contains general information only. It is not intended as financial product advice and must not be relied upon as such. You should consider obtaining independent advice tailored to your specific circumstances before making any financial decisions. Copyright in this publication is owned by PT. Dataindo Inti Swakarsa. The publication is sold on the basis that the purchaser agrees not to copy the material contained within it for other than the purchasers own purposes. In the event that the purchaser uses or quotes from the material in this publication - in papers, reports, or opinions prepared for any other person - it is agreed that it will be sourced to: PT. Dataindo Inti Swakarsa

Mrs. Muara Linda Sitanggang
Pyridam Farma Tbk., PT
Latest Updates 21-October-2024
Major Businessline : Pharmaceutical

PT. Dataindo Inti SwakarsaTelp : (62 - 21) 719 3832
3rd Floor, Gapura Raya BuildingTelp : (62 - 21) 719 3834
Jl. Bangka Raya No. 4, Pela Mampang Email : [email protected]
Jakarta 12720, Indonesia
Selective Member’s Information US $ Select
Position 0.35
Company's Address 0.20
Company's Telephone 0.15
Company's Email [0] 0.60
Business Activity 0.30
Selective Member`s Discount Price
US$
To become a Selective Member
Register
Is this person"s information incorect
or out-of-date?
Update Mrs. Muara Linda Sitanggang’s Information